Ledger.Open graph →
SEC Form D · filed June 22, 2015

Kezar Life Sciences, Inc

Offering
$28.4M
Sold
$28.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

John F. Fowler · South San Francisco, CAExec · DirectorDr. Gerald J. Chan · South San Francisco, CADirectorDr. Jean-Pierre J. Sommadossi · South San Francisco, CADirectorChristopher J. Kirk · South San Francisco, CAExec · DirectorJohn F. Fowler · South San Francisco, CAExec · DirectorDr. Gerald J. Chan · South San Francisco, CADirectorDr. Jean-Pierre J. Sommadossi · South San Francisco, CADirectorChristopher J. Kirk · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗